| Literature DB >> 26053522 |
Tadahito Saito1,2, Shinsuke Ohba3, Fumiko Yano1, Ichiro Seto1, Yoshiyuki Yonehara2, Tsuyoshi Takato1, Toru Ogasawara1.
Abstract
Previously, we reported that the transcription factor Nanog, which maintains the self-renewal of embryonic stem cells (ESCs), promotes the osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2 through a genome reprogramming process. In the present study, to clarify the mechanism underlying the multipotency of mesenchymal stem cells (MSCs) and to develop a novel approach to bone regenerative medicine, we attempted to identify the downstream effectors of Nanog in promoting osteogenic differentiation of mouse mesenchymal cells. We demonstrated that Runx1 and Runx3 are the downstream effectors of Nanog, especially in the early and intermediate osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26053522 PMCID: PMC4487263 DOI: 10.1089/cell.2014.0059
Source DB: PubMed Journal: Cell Reprogram ISSN: 2152-4971 Impact factor: 1.987